OR WAIT null SECS
March 29, 2021
The agency’s human medicines committee has approved new manufacturing sites for COVID-19 vaccines.
March 24, 2021
The agency says that data do not support the use of ivermectin to prevent or treat COVID-19 outside of clinical trials.
March 15, 2021
Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.
March 04, 2021
The European Medicines Agency has begun a rolling review based on laboratory and clinical studies of the Sputnik V (Gam-COVID-Vac).
The European Medicines Agency and Health Canada have published clinical data used to support the authorization of Moderna’s COVID-19 vaccine.
March 02, 2021
The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country’s competitiveness in pharma.
February 17, 2021
The European Medicines Agency announced it has started a review of drugs that contain amfepramone due to concerns that include heart problems and high blood pressure in the lungs.
The EC has granted marketing authorization to Celltrion Healthcare for its adalimumab biosimilar, Yuflyma (CT-P17).
February 11, 2021
EMA has clarified its position on the European approval process of the Sputnik V vaccine.